Monosodium alendronate
PubChem Notes:
Alendronate A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis.
Molecular Formula:
C4H12NNaO7P2
InChI: InChI=1/C4H13NO7P2.Na/c5-3-1-2-4(6,13(7,8)9)14(10,11)12;/h6H,1-3,5H2,(H2,7,8,9)(H2,10,11,12);/q;+1/p-1/fC4H12NO7P2.Na/h7-8,10H;/q-1;m
InChIKey: InChIKey=CAKRAHQRJGUPIG-AJQZKILTCQ
SMILES: C(CC(O)(P(=O)(O)O)P(=O)(O)[O-])CN.[Na+]
Names:
ALENDRONATE SODIUM
Fosamax
MK 217
Monosodium alendronate
Phosphonic acid, (4-amino-1-hydroxybutylidene)bis-, monosodium salt
sodium [4-amino-1-hydroxy-1-(hydroxy-oxido-phosphoryl)butyl]phosphonic acid
(4-Amino-1-hydroxybutylidene)bisphosphonic acid monosodium salt
129318-43-0
Registries:
PubChem CID 62958
PubChem ID 205143
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|